REAP Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
REAP Financial Group's LLY Position: Q3 2026 in Review
REAP Financial Group reduced its Eli Lilly (LLY) stake by 11% in Q3 2026, selling an estimated $63.7K and leaving 448 shares worth $518K. The position accounts for 0.08% of the portfolio, ranked #73.
REAP Financial Group first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $603K in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- REAP Financial Group held 448 shares of Eli Lilly worth $518K as of Q3 2026.
- REAP Financial Group sold 54 Eli Lilly shares in Q3 2026, an estimated $63.7K.
- Eli Lilly made up 0.08% of REAP Financial Group's portfolio in Q3 2026, its #73 holding.
- REAP Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- REAP Financial Group's Eli Lilly position peaked at $603K in Q2 2026.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on REAP Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.